Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,576
Closed -$128K 521
2023
Q2
$128K Buy
+1,576
New +$129K 0.2% 94
2019
Q3
Sell
-41,013
Closed -$1.99M 234
2019
Q2
$1.99M Buy
41,013
+10,294
+34% +$476K 1% 22
2019
Q1
$1.49M Buy
+30,719
New +$1.39M 0.94% 23
2017
Q3
Sell
-64,986
Closed -$2.95M 287
2017
Q2
$2.95M Buy
+64,986
New +$2.87M 0.71% 56
2016
Q1
Sell
-21,406
Closed -$828K 91
2015
Q4
$828K Buy
21,406
+3,464
+19% +$135K 0.33% 28
2015
Q3
$702K Sell
17,942
-7,012
-28% -$278K 0.46% 31
2015
Q2
$950K Buy
24,954
+8,778
+54% +$307K 0.29% 69
2015
Q1
$534K Buy
16,176
+1,392
+9% +$42.7K 0.17% 94
2014
Q4
$395K Buy
+14,784
New +$382K 0.14% 156

Other funds holding HOLX

USA Financial Formulas's HOLX Position: Q3 2023 in Review

USA Financial Formulas sold out of Hologic (HOLX) in Q3 2023, closing a stake of 1,576 shares — an estimated $128K sold.

USA Financial Formulas first reported a position in HOLX in Q4 2014 and held it in 9 quarters. The position peaked at $2.95M in Q2 2017. 693 funds tracked by Wall St. Rank hold HOLX as of Q3 2023.

  • USA Financial Formulas reported no remaining Hologic position as of Q3 2023 after selling out during the quarter.
  • USA Financial Formulas sold 1,576 Hologic shares in Q3 2023, an estimated $128K.
  • USA Financial Formulas first reported a position in Hologic in Q4 2014 and held it in 9 quarters.
  • USA Financial Formulas's Hologic position peaked at $2.95M in Q2 2017.
  • 693 funds tracked by Wall St. Rank held Hologic as of Q3 2023.

Based on USA Financial Formulas's 13F filing for Q3 2023, filed 27 Nov 2023.